Holders over time
- GH
- CI
| Quarter | GH | CI |
|---|---|---|
| Q3 2020 | 14 holders, $1.2bn | 34 holders, $18.1bn |
| Q4 2020 | 17 holders, $1.5bn | 22 holders, $21.9bn |
| Q1 2021 | 15 holders, $2.6bn | 24 holders, $23.9bn |
| Q2 2021 | 18 holders, $2.3bn | 31 holders, $22.5bn |
| Q3 2021 | 11 holders, $3.1bn | 30 holders, $17.8bn |
| Q4 2021 | 12 holders, $2.4bn | 26 holders, $20.1bn |
| Q1 2022 | 9 holders, $1.5bn | 28 holders, $20.4bn |
| Q2 2022 | 8 holders, $950m | 32 holders, $22.1bn |
| Q3 2022 | 9 holders, $1.3bn | 31 holders, $21.5bn |
| Q4 2022 | 11 holders, $731m | 30 holders, $24.7bn |
| Q1 2023 | 11 holders, $267m | 35 holders, $18.2bn |
| Q2 2023 | 14 holders, $752m | 30 holders, $19.8bn |
| Q3 2023 | 10 holders, $399m | 28 holders, $19.8bn |
| Q4 2023 | 9 holders, $433m | 31 holders, $20.6bn |
| Q1 2024 | 9 holders, $234m | 28 holders, $24.0bn |
| Q2 2024 | 9 holders, $323m | 28 holders, $19.5bn |
| Q3 2024 | 9 holders, $513m | 25 holders, $20.2bn |
| Q4 2024 | 11 holders, $599m | 23 holders, $15.2bn |
| Q1 2025 | 9 holders, $730m | 24 holders, $18.4bn |
| Q2 2025 | 10 holders, $843m | 34 holders, $19.5bn |
| Q3 2025 | 13 holders, $1.5bn | 28 holders, $16.2bn |
| Q4 2025 | 17 holders, $2.7bn | 21 holders, $14.6bn |
| Q1 2026 | 15 holders, $2.3bn | 26 holders, $13.5bn |
| Q2 2026 | 21 holders, $4.8bn | 28 holders, $13.0bn |
Guardant Health Inc
- Holders
- 10
- Reported value
- $843m
- Buyers
- 8
- Sellers
- 2
Breadth +6 among 95 comparable managers.
The Cigna Group
- Holders
- 34
- Reported value
- $19.5bn
- Buyers
- 24
- Sellers
- 10
Breadth +14 among 95 comparable managers.
Who holds both, Q2 2025
Both (4)
Man Group PLC, Renaissance Technologies LLC, Two Sigma Advisers LP, Two Sigma Investments LP
Only GH (6)
ARK Investment Management LLC, Baillie Gifford & Co, Farallon Capital Management LLC, Millennium Management LLC, PDT Partners LLC, Polen Capital Management LLC
Only CI (30)
Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Freestone Grove Partners LP, GAMCO Investors Inc, Glenview Capital Management LLC, Greenlight Capital, Invesco Ltd, Jane Street Group LLC, Marshall Wace LLP, MFS Investment Management, Moore Capital Management LP, Neuberger Berman Group LLC, and 5 more
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.